Dr. Pankaj Naram'S Sanjeevani India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.06 M
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -25.09%
- Profit Growth 766.24%
- Ebitda 63.57%
- Net Worth 26.79%
- Total Assets -25.58%
About Dr. Pankaj Naram'S Sanjeevani India
Dr. Pankaj Naram's Sanjeevani India Private Limited (DPNSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2009 and has a history of 15 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Sanjeevani Youth India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.06 M, as per Ministry of Corporate Affairs (MCA) records.
Smita Naram and Krushna Naram serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100MH2009PTC193574
-
Company No.
193574
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jun 2009
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dr. Pankaj Naram'S Sanjeevani India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Naram
|
Director | 16-Mar-2021 | Current |
|
Krushna Naram
|
Director | 29-Oct-2021 | Current |
Financial Performance of Dr. Pankaj Naram'S Sanjeevani India.
Dr. Pankaj Naram'S Sanjeevani India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 25.09% decrease. The company also saw a substantial improvement in profitability, with a 766.24% increase in profit. The company's net worth Soared by an impressive increase of 26.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Pankaj Naram'S Sanjeevani India?
In 2020, Dr. Pankaj Naram'S Sanjeevani India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ayushakti Ayurved Private LimitedSmita Naram is a mutual person
-
Ayushakti Wellness Private Limited
Smita Naram is a mutual person
-
Secret Of Healing LlpKrushna Naram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Pankaj Naram'S Sanjeevani India?
Unlock and access historical data on people associated with Dr. Pankaj Naram'S Sanjeevani India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Pankaj Naram'S Sanjeevani India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Pankaj Naram'S Sanjeevani India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
